Resource Logo
HIV i-Base

18th Annual BHIVA Conference, 18-20 April 2012, UK




 

This year the BHIVA spring conference was held in Birmingham and as usual it included both important national research and impressive international speakers.

In addition to more than 40 oral presentations, the meeting included case studies and over 230 posters.

The selection of reports below only highlights some of these studies. For further details please see the full programme and contact the researchers directly.

The abstracts from the conference are available free online as a PDF supplement to the April edition of HIV Medicine.

http://onlinelibrary.wiley.com/doi/10.1111/hiv.2012.13.issue-s1/issuetoc

As with previous years, some of these sessions will be available as webcasts and some of the slide presentations can be viewed or downloaded from the conference website.

http://www.bhiva.org

Reports in this issue include:

  • Half of gay men in London interested in daily PrEP to reduce risk of HIV
  • Recent infection is common in UK; 30% gay men aged 15-25 infected within a year of diagnosis
  • One third of HIV positive people at five UK clinics have symptomatic depression: link to adherence and viral suppression – 40% cases are untreated
  • Hodgkin’s lymphoma: survival normalises to HIV negative rates despite more advanced disease at diagnosis
  • Promising outcomes from laser ablative treatment of AIN 2/3 to prevent anal cancer
  • KS in the HAART era includes patients with high CD4 and suppressed viral load: importance of KS chemotherapy for some patients in addition to ART
  • 3rd vs 4th generation HIV testing: almost half of UK clinics out of step with national guidelines
  • Case reports of complications from ketamine use in two MSM on ritonavir-based combinations
  • Intranasal and topical corticosteroids and risk of Cushing’s symptoms in HIV patients on ritonavir-based combinations
  • Outcomes from switches to atazanavir/r in London
  • Intimate partner violence towards HIV positive women in the UK

Links to external websites are current at time of posting but not maintained.



 


Copyright © 2012 -HIV i-Base, Publisher. All rights reserved to I-BASE HIV Treatment Bulletin. Permission to reproduce courtesy of HIV i-Base, Third Floor East, Thrale House, 44-46 Southwark Street, London SE1 1UN - T: +44 (0) 20 7410 8488 F: +44 (0) 20 7410 8489 I-BASE HIV Treatment

Information in this article was accurate in June 4, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.